ErmolaevaO., RastogiM., PruittK.D.Data management and analysis for gene expression arrays.Nat Genet1998; 20: 19–23.
2.
ThompsonM.The Cry and the Covenant.New York: Doubleday & Company, Inc., 1949.
3.
NulandS.B.The Doctors’ Plague: Germs, Childbed Fever, and the Strange Story of Ignaz Semmelweis.New York: W.W. Norton & Company, Inc., 2003.
4.
WeinsteinR.Nosocomial infection update.Emerging Infectious Diseases. July 1998. Available at http://www.cdc.gov/NCIdod/eid.
5.
RichardsM.J., EdwardsH.R., CulverD.H., GaynesR.P.Nosocomial infections in combined medical-surgical intensive care units in the United States.Infect Control Hosp Epidemiol2000; 21: 510.
6.
DeLisleS., PerlTmVancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance.Chest2003; 123: 504S–18S.
7.
MarshallB., ed. Helicobacter Pioneers.Tokyo: Blackwell Publishing, 2002. [These essays provided the details of the H. pylori story told above]
8.
van de VijverM.J., HeY.D., Van't VeerL.J.A gene-expression signature as a predictor of survival in breast cancer.N Engl J Med2002; 347: 1999–2009.
9.
PaikS., ShakS., TangG.A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.N Engl J Med2004; 351: 2817–26.
10.
PaikS., ShakS., TangG.Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20.Breast Cancer Research and Treatment2004; 88: A-24.
11.
KallooA.N., SinghV.K., JagannathS.B.Flexible trans-gastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity.Gastrointest Endosc2004; 60: 114–7.
12.
NicholiA.M.Jr.The Question of God.New York: The Free Press, 2002.
13.
JohnsonT.Finding God in the Questions.Downers Grove, IL: InterVarsity Press, 2004.